ZA886507B - Azolidinedione derivatives - Google Patents

Azolidinedione derivatives

Info

Publication number
ZA886507B
ZA886507B ZA886507A ZA886507A ZA886507B ZA 886507 B ZA886507 B ZA 886507B ZA 886507 A ZA886507 A ZA 886507A ZA 886507 A ZA886507 A ZA 886507A ZA 886507 B ZA886507 B ZA 886507B
Authority
ZA
South Africa
Prior art keywords
azolidinedione derivatives
azolidinedione
derivatives
Prior art date
Application number
ZA886507A
Other languages
English (en)
Inventor
Steven Wayne Goldstein
Wayne Goldstein Steven
Reinhard Sarges
Sarges Reinhard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA886507B publication Critical patent/ZA886507B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA886507A 1987-09-04 1988-09-01 Azolidinedione derivatives ZA886507B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/002196 WO1989001775A1 (en) 1987-09-04 1987-09-04 Azolidinedione derivatives

Publications (1)

Publication Number Publication Date
ZA886507B true ZA886507B (en) 1990-04-25

Family

ID=22202540

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA886507A ZA886507B (en) 1987-09-04 1988-09-01 Azolidinedione derivatives

Country Status (21)

Country Link
EP (1) EP0306251A3 (ko)
JP (1) JPS6471882A (ko)
KR (1) KR900008841B1 (ko)
CN (1) CN1022325C (ko)
AU (1) AU595467B2 (ko)
CS (1) CS273186B2 (ko)
DD (1) DD273381A5 (ko)
DK (1) DK488688A (ko)
EG (1) EG18591A (ko)
FI (1) FI901087A0 (ko)
HU (1) HU204832B (ko)
IL (1) IL87590A (ko)
MX (1) MX12896A (ko)
MY (1) MY103765A (ko)
NO (1) NO901016L (ko)
PH (1) PH24957A (ko)
PL (1) PL156798B1 (ko)
PT (1) PT88407B (ko)
WO (1) WO1989001775A1 (ko)
YU (1) YU46863B (ko)
ZA (1) ZA886507B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
AU2006240772B2 (en) * 2005-04-21 2011-11-10 Ishihara Sangyo Kaisha, Ltd. Method for producing nicotinic acid derivative or salt thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
ATE11781T1 (de) * 1981-05-13 1985-02-15 Imperial Chemical Industries Plc Pharmazeutische zubereitungen, die spirosuccinimidderivate enthalten.

Also Published As

Publication number Publication date
KR890005112A (ko) 1989-05-11
EP0306251A3 (en) 1990-08-01
MY103765A (en) 1993-09-30
MX12896A (es) 1993-06-01
PT88407A (pt) 1989-07-31
CS591188A2 (en) 1990-06-13
NO901016L (no) 1990-05-02
EG18591A (en) 1993-06-30
KR900008841B1 (ko) 1990-11-30
PT88407B (pt) 1992-10-30
HUT56106A (en) 1991-07-29
PL156798B1 (pl) 1992-04-30
IL87590A0 (en) 1989-01-31
JPS6471882A (en) 1989-03-16
EP0306251A2 (en) 1989-03-08
YU167788A (en) 1990-06-30
FI901087A0 (fi) 1990-03-02
IL87590A (en) 1992-07-15
PL274504A1 (en) 1989-05-02
CS273186B2 (en) 1991-03-12
CN1022325C (zh) 1993-10-06
DD273381A5 (de) 1989-11-15
HU204832B (en) 1992-02-28
JPH0583554B2 (ko) 1993-11-26
CN1031702A (zh) 1989-03-15
DK488688A (da) 1989-04-07
DK488688D0 (da) 1988-09-02
AU595467B2 (en) 1990-03-29
WO1989001775A1 (en) 1989-03-09
YU46863B (sh) 1994-06-24
AU2184188A (en) 1989-03-09
PH24957A (en) 1990-12-26
NO901016D0 (no) 1990-03-02

Similar Documents

Publication Publication Date Title
YU234188A (en) Adenozine derivatives
GB8815258D0 (en) Thiorea derivatives
EP0318704A3 (en) 3-cyano-4-phenyl-pyrrole derivatives
ZA881808B (en) Propiolophenone derivatives
EP0305322A3 (en) Isoxazole-beta-carboline derivatives
GR3000964T3 (en) Hydroxyethyl-azolyl derivatives
ZA888359B (en) 3-cyano-4-phenyl-pyrrole derivatives
GB2205829B (en) 2-aryl-4-isoxazolin-3-one derivatives
EP0322164A3 (en) Ethanolamie derivatives
GB8705601D0 (en) Oxo-isoindolinyl derivatives
PH24957A (en) Azolidinedione derivatives
GB8726272D0 (en) 4-demethoxy anthra-cycline derivatives
GB2200910B (en) Thiopilocarpine derivatives
GB8704236D0 (en) Anthracycline-oestrone derivatives
GB8700016D0 (en) Quinolizinone derivatives
ZA884683B (en) Hydroxyethyl-azolyl derivatives
GB8715925D0 (en) Thiapentanamide derivatives
IE882666L (en) Azolidinedione derivatives
GB2211840B (en) Indenofuran derivatives
FI103571B1 (fi) Propoksibentseenijohdannaisia
IE870091L (en) Azabicyclo-benzyloxyphenyl-urea derivatives
IE870634L (en) Arylazolylmethylbenzocycloalkene derivatives
IE871782L (en) 18-phenyloestrane derivatives
IE871081L (en) Thiadiazinone - tricyclic derivatives
IE871047L (en) Alkenamide derivatives